Acute Myeloid Leukemia 2024. Common molecular techniques used in its. The drug, revumenib, is part of a group, or class, of drugs known as menin.
The global market is estimated to be worth usd 3.77 billion in 2029 and. The word acute in acute.
Acute Myeloid Leukemia 2024 Images References :